Search

Author/Creator Jiang, Run-Xue

1. Comparison of apatinib and capecitabine (Xeloda) with capecitabine (Xeloda) in advanced triple-negative breast cancer as third-line therapy: A retrospective study. Issue 36 (September 2018)

Authors:
Li, Yi-Hui; Zhou, Yang; Wang, Yu-Wei; Tong, Ling; Jiang, Run-Xue; Xiao, Lei; Zhang, Guang-Ju; Xing, Shu-Shan; Qian, Fang; Feng, Jing-Qi; Zhao, Ya-Ling; Wang, Jian-Gong; Wang, Xiao-Hong
Other Names:
Staege. Martin S. section editor.
Journal:
Medicine
Issue:
Volume 97:Issue 36(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search